Home | Current Article | What is PXE? | Contact NAPE |

Membership Form | PXE Pals | Q & A | Amsler Grid






PXE Patient Avastin Experience


click to listen (284 KB)


My husband has PXE and has been battling vision loss for almost two years. His retina specialist has fought hard to stabilize his vision with Kenalog injections, Photodynamic Therapy and a clinical study involving anecortave acetate. But to no avail, his vision continued to get worse. In August 2005 his vision was around 20/150. In November 2005, my husband started receiving Avastin intravitreal injections. He has received a total of six injections and is happy to report his vision has improved to 20/70 and stabilized. He is currently on an "as-needed" basis and at $280/shot, we will continue treatments and financial burden as long as he benefits.

We recently heard from his doctor's office, Medicare is in the process of approving Avastin for its "off-label" use, however they could not tell us whether Medicare will approve it for just AMD or for all inflammatory choroidal neovascularizations Ð including PXE. Have you heard anything regarding this pending approval? Is NAPE advocating this treatment for patients with PXE?

- Patient Name Withheld On Request



Back to Table of Contents

Home | Current Article | What is PXE? | Contact NAPE |

Membership Form | PXE Pals | Q & A | Amsler Grid